ReviewCJC open2026
Closing the Gaps in Heart Failure Care: A Call for a National Strategy in Canada.
Review in CJC open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure (HF) is a growing public health challenge in Canada, affecting over 787,000 individuals and contributing substantially to morbidity, mortality, and health care costs. Despite advances in therapies, HF care delivery remains fragmented, with significant variability in access to diagnostics, specialized services, and guideline-directed medical therapy (GDMT). Critically, the challenge is not a lack of evidence, but rather gaps in coordination, implementation, and accountability. Three dominant system-level issues drive poor outcomes: delayed diagnosis, vulnerability during transitions of care, and GDMT underuse. These are further compounded by geographic and sociodemographic disparities, particularly in rural, remote, and Indigenous communities, as well as the absence of standardized performance metrics and accountability frameworks. Evidence from national and international health care systems demonstrates that coordinated, data-driven approaches---incorporating standardized care pathways, performance measurement, and system-level accountability---can improve outcomes and efficiency. Early diagnosis, timely specialist follow-up, GDMT optimization, and multidisciplinary care models are associated with fewer hospitalizations, improved survival, and lower costs. Addressing these gaps will require a coordinated national strategy. Near-term priorities include establishing a national HF strategy, expanding access to diagnostic testing and improving GDMT access. Medium-term priorities include implementing standardized care pathways, strengthening care coordination, and enhancing data infrastructure to support performance measurement and quality improvement. Over the longer term, integrating HF into broader chronic disease frameworks and scaling digital solutions will be essential to ensure sustained coordination, accountability, and equitable access. Bill S-204 provides a critical opportunity to align key partners and advance a comprehensive, patient-centred, evidence-informed approach to HF care in Canada.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.